"Macula Lutea" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An oval area in the retina, 3 to 5 mm in diameter, usually located temporal to the posterior pole of the eye and slightly below the level of the optic disk. It is characterized by the presence of a yellow pigment diffusely permeating the inner layers, contains the fovea centralis in its center, and provides the best phototropic visual acuity. It is devoid of retinal blood vessels, except in its periphery, and receives nourishment from the choriocapillaris of the choroid. (From Cline et al., Dictionary of Visual Science, 4th ed)
| Descriptor ID |
D008266
|
| MeSH Number(s) |
A09.371.729.522
|
| Concept/Terms |
Macula Lutea- Macula Lutea
- Lutea, Macula
- Luteas, Macula
- Macula Luteas
|
Below are MeSH descriptors whose meaning is more general than "Macula Lutea".
Below are MeSH descriptors whose meaning is more specific than "Macula Lutea".
This graph shows the total number of publications written about "Macula Lutea" by people in this website by year, and whether "Macula Lutea" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2002 | 1 | 0 | 1 |
| 2003 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 2 | 0 | 2 |
| 2017 | 0 | 2 | 2 |
| 2018 | 3 | 0 | 3 |
| 2019 | 2 | 1 | 3 |
| 2020 | 1 | 0 | 1 |
| 2021 | 3 | 0 | 3 |
| 2022 | 1 | 0 | 1 |
| 2024 | 0 | 1 | 1 |
| 2025 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Macula Lutea" by people in Profiles.
-
Initiation of a global consortium to study the progression of age-related macular degeneration: RIMR AMD consortium report # 1. Graefes Arch Clin Exp Ophthalmol. 2026 Apr; 264(4):935-943.
-
Predictors of persistent central serous chorioretinopathy: a multicenter retrospective study?- MICRoN report number four. Graefes Arch Clin Exp Ophthalmol. 2026 Jan; 264(1):73-80.
-
Anatomic biomarkers as potential endpoints in diabetic macular edema: A systematic literature review with identification of macular volume as a key surrogate for visual acuity. Surv Ophthalmol. 2025 Nov-Dec; 70(6):1090-1110.
-
Clinical Characteristics and Progression of Pachychoroid Macular Atrophy in Central Serous Chorioretinopathy. Ophthalmol Retina. 2025 Oct; 9(10):984-993.
-
Evaluation of macular retinal oximetry across different levels of diabetic retinopathy: a cross sectional study. BMC Ophthalmol. 2025 Jan 17; 25(1):24.
-
CLINICALLY RELEVANT POSTERIOR VITREOUS DETACHMENT STAGING USING CIRCUMPAPILLARY AND MACULAR VOLUME OPTICAL COHERENCE TOMOGRAPHY. Retina. 2024 08 01; 44(8):1441-1448.
-
PARACENTRAL ACUTE MIDDLE MACULOPATHY IN GIANT CELL ARTERITIS. Retin Cases Brief Rep. 2024 May 01; 18(3):285-289.
-
Total retinal thickness: a neglected factor in the evaluation of inner retinal thickness. BMJ Open Ophthalmol. 2022 09; 7(1).
-
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials. Lancet. 2022 02 19; 399(10326):741-755.
-
Acute Macular Neuroretinopathy Secondary to Rickettsia typhi Infection. J Neuroophthalmol. 2023 09 01; 43(3):e67-e69.